METRNL also shows an anti-inflammatory role, especially in reducing adipose inflammation, increasing the expression of M2 macrophages in adipose tissue, and improving insulin resistance typical of obesity [62]. This evidence concerns the gene METRNL and obesity due to melanocortin 4 receptor deficiency.